Effects of acetazolamide on insulin release, serum glucose and insulin, glucose tolerance, and alloxan sensitivity of mice.
Isolated pancreatic islets exposed to 100 mM acetazolamide (AZM) and low glucose concentration exhibited increased insulin release, whereas those subjected to AZM and high glucose concentration exhibited decreased secretion of insulin. A slight transient hyperglycaemia was found 24 h after administration of 1.5 g/kg b.wt. of AZM to fed mice, whereas no such response was seen in starved mice. The serum insulin concentration was increased in the 24 h after AZM injection. Pretreatment with AZM caused decreased glucose tolerance and protection against alloxan toxicity. Inhibited carbonic anhydrase activity and ionic alterations might have played a role in the development of these effects of AZM in mice.
D000086:Acetazolamide / Q000494:pharmacology*; D000496:Alloxan / Q000633:toxicity*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis*; D002256:Carbonic Anhydrases / Q000378:metabolism; D005951:Glucose Tolerance Test; D006943:Hyperglycemia / Q000139:chemically induced; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D051379:Mice
D001786:Blood Glucose; D007328:Insulin; D000496:Alloxan; D002256:Carbonic Anhydrases; D000086:Acetazolamide